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StriatumIn the present report 15 day-old Wistar rats were injected with 0.3 μmol of diphenyl ditelluride (PhTe)2/kg
body weight and parameters of neurodegeneration were analyzed in slices from striatum 6 days afterwards.
We found hyperphosphorylation of intermediate ﬁlament (IF) proteins from astrocyte (glial ﬁbrillary acidic
protein—GFAP and vimentin) and from neuron (low-, medium- and high molecular weight neuroﬁlament
subunits: NF-L, NF-M and NF-H, respectively) and increased MAPK (Erk, JNK and p38MAPK) as well as PKA
activities. The treatment induced reactive astrogliosis in the striatum, evidenced by increased GFAP and
vimentin immunocontent as well as their mRNA overexpression. Also, (PhTe)2 signiﬁcantly increased the
propidium iodide (PI) positive cells in NeuN positive population without altering PI incorporation into
GFAP positive cells, indicating that in vivo exposure to (PhTe)2 provoked neuronal damage. Immunohisto-
chemistry showed a dramatic increase of GFAP staining characteristic of reactive astrogliosis. Moreover, in-
creased caspase 3 in (PhTe)2 treated striatal slices suggested apoptotic cell death. (PhTe)2 exposure
decreased Akt immunoreactivity, however phospho-GSK-3-β (Ser9) was unaltered, suggesting that this ki-
nase is not directly implicated in the neurotoxicity of this compound. Therefore, the present results shed
light into the mechanisms of (PhTe)2-induced neurodegeneration in rat striatum, evidencing a critical role
for the MAPK and Akt signaling pathways and disruption of cytoskeletal homeostasis, which could be related
with apoptotic neuronal death and astrogliosis.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Tellurium (Te) applications in electronics, optics, batteries andmining
industries have expanded during the last fewyears, leading to an increase
in environmental Te contamination, thus renewing biological interest in
Te toxicity. The main target sites for Te toxicity are the kidney, nervous
system, skin, and the fetus (hydrocephalus) (Taylor, 1996). Nevertheless,
several reports support that inorganic and organic tellurium compoundsintermediate ﬁlament; NF,
NF-L, low molecular weight
eight neuroﬁlament subunit;
PK, mitogen-activated protein
n N-terminus kinase 1 and 3;
almodulin-dependent protein
ase.
io Grande do Sul, Instituto de
ca, Rua Ramiro Barcelos 2600
3308 5535.
.
evier OA license.are highly toxic to the CNS of rodents (Maciel, 2000). Organotellurium
compounds lead to degradation of the myelin sheath and consequently
a transient demyelination of peripheral nerves (Nogueira et al., 2004).
Neuroﬁlaments (NF) are the primary intermediate ﬁlaments (IF)
in mature neurons. They assemble from three subunit polypeptides
of low, medium and high molecular weight, NF-L, NF-M, and NF-H,
respectively. This process is ﬁnely regulated via phosphorylation of
lysine–serine–proline (KSP) repeats in the carboxyl-terminal domain
of NF-M and NF-H. The majority of KSP repeats in rat-mouse NF tail
domains are phosphorylated by mitogen-activated protein kinases
(MAPK) (Veeranna et al., 1998); glycogen synthetase kinase 3
(GSK3) (Guan et al., 1991); p38MAPK (Ackerley et al., 2004;) and
c-Jun N-terminus kinase 1 and 3 (JNK1/3) (Brownlees et al., 2000).
Otherwise, phosphorylation sites located on the amino-terminal do-
mains of the three NF subunits are the targets of second messenger-
dependent protein kinases, such as cAMP-dependent protein kinase
(PKA), Ca2+/calmodulin-dependent protein kinase (PKCaM) and Ca2+/
diacylglycerol-dependent protein kinase (PKC) (Sihag and Nixon, 1990).
The correct formation of an axonal network of NF is crucial for the estab-
lishment andmaintenance of axonal caliber and consequently for the op-
timization of conduction velocity.
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GFAP expression is essential for normal white matter architecture and
blood–brain barrier integrity, and its absence leads to late-onset CNS
dysmyelination (Liedtke et al., 1996).
There is now compelling evidence for the critical role of the cyto-
skeleton in neurodegeneration (Lee et al., 2011). Moreover, aberrant
NF phosphorylation is a pathological hallmark of many human neuro-
degenerative disorders as well as is found after stressor stimuli (Sihag
et al., 2007).
While NF abnormalities in neurodegenerative disorders could
simply reﬂect a pathological consequence of neuronal dysfunction,
recent studies suggested that disruption of NF homeostasis itself can
also produce deleterious effects and therefore could contribute to
the neurodegeneration process (for review see Perrot and Eyer,
2009).
Cell death and neuronal loss are the key pathological hallmarks of
neurodegeneration in all neurodegenerative disorders, with apopto-
sis and necrosis being central to both acute and chronic degenerative
processes. In this context, the activation of p38MAPK signaling path-
way is involved in the development of motor neuron degeneration of
the spinal cord. In addition, JNK pathways include important media-
tors of neurodegeneration beyond NF substrates (Gelderblom et al.,
2004).
Also, astrogliosis is a hallmark of diseased CNS tissue (Pekny and
Nilsson, 2005). This term refers to progressive changes in gene ex-
pression and cellular morphology, often including proliferation. The
activation of astrocytes is characterized by changes in their molecular
and morphological features. Although reactive astrogliosis is the nor-
mal physiological response essential for damage containment, it can
also have detrimental effects on neuronal survival and axon regener-
ation, particularly in neurodegenerative diseases. It is believed that
progressive changes in astrocytes as they become reactive are ﬁnely
regulated by complex intercellular and intracellular signaling mecha-
nisms. The most commonly used marker of activated astrocytes is
their upregulation of GFAP, vimentin, and to some extent nestin, coin-
cident with cellular hypertrophy (Sofroniew and Vinters, 2010).
Previous data from literature have indicated that diphenyl ditelluride
(PhTe)2 is extremely neurotoxic to rodents and exposure to low doses of
this compound can cause profound neurostructural and neurofunctional
deregulation in experimental animals (Stangherlin et al., 2009). Further-
more, (PhTe)2 can also have neurotoxic effects in vitro, including cyto-
toxic effect in astrocytes (Roy and Hardej, 2011) and changes in the
phosphorylation of IF in slices obtained from different brain structures
of young rats (Heimfarth et al., 2011, 2012). Therefore, in an attempt
to better understand the toxicity of organotellurium compounds, we
studied the effect of (PhTe)2 in the striatum of young rats acutely ex-
posed to the same concentration of the neurotoxicant able to provoke
systemic toxicity and to induce hyperphosphorylation of cytoskeletal
proteins in cerebral cortex of rats (Heimfarth et al., 2008). Thus, in the
present report we describe disruption of the cytoskeletal homeostasis,
reactive astrogliosis and apoptotic neuronal death in rat striatum early
after (PhTe)2 injection.
Material and methods
Radiochemicals and compounds
[32P]Na2HPO4 was purchased from CNEN, São Paulo, Brazil.
Benzamidine, leupeptin, antipain, pepstatin, chymostatin, acrylamide
and bis-acrylamide, anti-GSK3β, anti-phosphoGSK3β, anti-PKAcα, anti-
PKCaMII, anti-active caspase 3, anti-AKT, anti-phosphoAKT, anti-GFAP,
anti-vimentin, anti-NF-L, anti-NF-M, anti-NF-Hantibodies andpropidium
iodide were obtained from Sigma (St. Louis, MO, USA). The chemi-
luminescence ECL kit peroxidase and the conjugated anti- rabbit IgG
were obtained from Amersham (Oakville, Ontario, Canada). Anti-ERK,
anti-phosphoERK, anti-SAP/JNK, anti-phosphoSAP/JNK, anti-p38, anti-phosphop38 and anti-KSP repeats, were obtained from Cell Signaling
Technology (USA). Anti-phosphoSer55NF-L, anti-phosphoSer57NF-L
and anti-NeuN antibodies were obtained from Millipore. Anti-rabbit
Alexa 488 and anti-mouse Alexa 568 were purchased from Molecular
Probes. The organochalcogenide (PhTe)2 was synthesized using the
method described by Petragnani (1994). Analysis of the 1H NMR and
13C NMR spectra showed that the compound obtained presented ana-
lytical and spectroscopic data in full agreement with their assigned
structures. The purity of the compoundswas assayed by high resonance
mass spectroscopy (HRMS) and was higher that 99.9%. Diphenyl
ditelluride was dissolved in canola oil just before use. Platinum Taq
DNA polymerase and SuperScript-II RT pre-amplication system were
obtained from Invitrogen. All other chemicals were of analytical grade
and were purchased from standard commercial supplier.
Animals
Fifteen day-old male and female Wistar rats were obtained from
our breeding stock. Rats were maintained on a 12-h light/12-h dark
cycle in a constant temperature (22 oC) colony room. On the day of
birth the litter size was culled to seven pups. Litters smaller than
seven pups were not included in the experiments. Water and a 20%
(w/w) protein commercial chow were provided ad libitum. The ex-
perimental protocol followed the “Principles of Laboratory Animal
Care” (NIH publication 85‐23, revised 1985) and was approved by
the Ethics Committee for Animal Research of the Federal University
of Rio Grande do Sul.
Drug administration, preparation and labeling of slices
Fifteen day-old Wistar rats were treated with a single subcutane-
ous (s.c.) injection of (PhTe)2 0.3 μmol/kg body weight or canola oil
(vehicle) (2.8 ml/kg body weight). Six days after treatment the rats
were killed by decapitation, the striatum was dissected onto Petri
dishes placed on ice and cut into 400 μm thick slices with a McIlwain
chopper.
Preincubation
Tissue slices were initially preincubated at 30 °C for 20 min in a
Krebs–Hepes medium containing 124 mM NaCl, 4 mM KCl, 1.2 mM
MgSO4, 25 mM Na–HEPES (pH 7.4), 12 mM glucose, 1 mM CaCl2,
and the following protease inhibitors: 1 mM benzamidine, 0.1 μM
leupeptin, 0.7 μM antipain, 0.7 μM pepstatin and 0.7 μM chymostatin.
In vitro 32P incorporation experiments
After preincubation, the mediumwas changed and incubation was
carried out at 30 °C with 100 μl of the basic medium containing
80 μCi of [32P] orthophosphate. The labeling reaction was normally
allowed to proceed for 30 min at 30 °C and stopped with 1 ml of
cold stop buffer (150 mM NaF, 5 mM, EDTA, 5 mM EGTA, Tris–HCl
50 mM, pH 6.5), and the protease inhibitors described above. Slices
were then washed twice with stop buffer to remove excess
radioactivity.
Preparation of the high salt-Triton insoluble cytoskeletal fraction from
tissue slices
After incubation, preparations of IF-enriched cytoskeletal fractions
were obtained from the striatum of rats. After the labeling reaction,
slices (8 slices/striatum in a total of 8 controls and 8 treated rats)
were homogenized in 400 μl of ice-cold high salt buffer containing
5 mM KH2PO4, (pH 7.1), 600 mM KCl, 10 mM MgCl2, 2 mM EGTA,
1 mM EDTA, 1% Triton X-100 and the protease inhibitors described
above. The homogenate was centrifuged at 15,800×g for 10 min at
Table 1
Primers used for qPCR (quantitative polymerase chain reaction).
Forward Primer Reverse Primer
GFAP 5′CAGAAGCTCCAAGATGAAACCAA 5′TCTCCTCCTCCAGCGACTCAAC
Vim 5′CCCAGATTCAGGAACAGCAT 5′CACCTGTCTCCGGTATTCGT
NF-L 5′CCATGCAGGACACAATCAAC 5′CTGCAAGCCACTGTAAGCAG
NF-M 5′GAGATGTATTACGCAAAGTACG5′ 5′CCAGTATGACCTTTATTGAGC
NF-H 5′ACCTATACCCGAATGCCTTCTT 5′AGAAGCACTTGGTTTTATTGCAC
Β-actin 5′TATGCCAACACAGTGCTGTCGG 5′TACTCCTGCTTCCTGATCCACAT
TBP 5′CCCCACAACTCTTCCATTCT 5′GCAGGAGTGATAGGGGTCAT
GFAP, glial ﬁbrillary acidic protein; Vim, vimentin; NF-L, low molecular weight
neuroﬁlament subunit; NF-M, middle molecular weight neuroﬁlament subunit; NF-H,
high molecular weight neuroﬁlament subunit; TBP, TATA box binding protein.
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pellet homogenized with the same volume of the high salt medium.
The resuspended homogenate was centrifuged as described and the
supernatant was discarded. The Triton-insoluble IF-enriched pellet,
containing NF subunits, Vim and GFAP, was dissolved in 1% SDS and
protein concentration was determined.
Polyacrylamide gel electrophoresis (SDS-PAGE)
The cytoskeletal fraction was prepared as described above. Equal
protein concentrations were loaded onto 10% polyacrylamide gels
and analyzed by SDS-PAGE. After drying, the gels were exposed to
T-MAT ﬁlms at−70 °C with intensifying screens and ﬁnally the auto-
radiograph was obtained. Cytoskeletal proteins were quantiﬁed by
scanning the ﬁlms with a Hewlett-Packard Scanjet 6100C scanner
and determining optical densities with an Optiquant version 02.00
software (Packard Instrument Company, Meriden, CT 06450 USA).
Density values were obtained for the studied proteins.
Preparation of total protein homogenate
Tissues slices were homogenized in 100 μl of a lysis solution
containing 2 mM EDTA, 50 mM Tris–HCl, pH 6.8, 4% (w/v) SDS. For
electrophoresis analysis, samples were dissolved in 25% (v/v) of solu-
tion containing 40% glycerol, 5% mercaptoethanol, 50 mM Tris–HCl,
pH 6.8 and boiled for 3 min.
Western blot analysis
Protein homogenate (80 μg) was analyzed by SDS-PAGE and trans-
ferred to nitrocellulose membranes (Trans-blot SD semi-dry transfer
cell, BioRad) for 1 h at 15 V in transfer buffer (48 mM Trizma, 39 mM
glycine, 20% methanol and 0.25% SDS). The nitrocellulose membranes
were washed for 10 min in Tris-buffered saline (TBS; 0.5 M NaCl,
20 mM Trizma, pH 7.5), followed by 2 h incubation in blocking solution
(TBS plus 5%bovine serumalbumin and0.1% Tween20). After incubation,
the blot was washed twice for 5 min with TBS plus 0.05% Tween-20
(T-TBS), and then incubated overnight at 4 °C in blocking solution
containing the following antibodies: anti-GFAP (clone G-A-5) diluted
1:500, anti-vimentin (Vim 13–12) diluted 1:400, anti-NF-L (clone NR-4)
diluted 1:1000, anti- NF-M (clone clone NN-18) diluted 1:400, anti-
NF-H (clone N52) diluted 1:1000, anti-ERK1/2 diluted 1:1000, anti-
phosphoERK diluted 1:1000, anti-/JNK diluted 1:1000, anti-phosphoJNK
(clone 98F2) diluted 1:1000, anti-p38MAPK (clone A-12) diluted
1:1000, anti-phosphop38MAPK diluted 1:1000, anti-PKAcα diluted
1:1000, anti-PKCaMII diluted 1:500, anti-AKT (clone 2H10) diluted
1:1000, anti-phosphoAKT (clone 244F9) diluted 1:1000, anti-active
caspase 3 diluted 1:1000, anti-GSK3β (clone 27C10) diluted 1:1000,
anti-phosphoGSK3β, anti-KSP repeats (clone NP1) diluted 1:1000, anti-
phoshoNF-LSer55 diluted 1:800, anti-phosphoNF-LSer57 diluted 1:1000
or anti-actin diluted 1:1000. The blot was then washed twice for 5 min
with T-TBS and incubated for 2 h in blocking solution containing peroxi-
dase conjugated anti-rabbit IgG diluted 1:2000 or peroxidase conjugated
anti-mouse IgG diluted 1:2000. The blot was washed twice again for
5 minwith T-TBS and twice for 5 minwith TBS. The blot was then devel-
oped using a chemiluminescence ECL kit. Immunoblots were quantiﬁed
by scanning the ﬁlms with a Hewlett-Packard Scanjet 6100C scanner
and determining optical densities with an OptiQuant version 02.00 soft-
ware (Packard Instrument Company). Optical density values were
obtained for the studied proteins.
RNA extraction, cDNA synthesis and quantitative PCR
RNA was isolated from striatum using the TRIzol Reagent
(Invitrogen). Approximately 2 μg of total RNA were added to each
cDNA synthesis reaction using the SuperScript-II RT pre-amplicationsystem. Reactions were performed at 42 °C for 1 h using the primer
T23 V (5′ TTT TTT TTT TTT TTT TTT TTTTTV). Quantitative PCR ampli-
ﬁcation was carried out using speciﬁc primer pairs designed with
Oligo Calculator version 3.02 (http://www.basic.nwu.edu/biotools/
oligocalc.html) and synthesized by IDT (MG, Brazil). The sequences
of the primers used are listed in Table 1. Quantitative PCRs were car-
ried out in an Applied-Biosystem StepOne Plus real-time cycler and
done in quadruplicate. Reaction settings were composed of an initial
denaturation step of 5 min at 95 °C, followed by 40 cycles of 10 s at
95 °C, 10 s at 60 °C, 10 s at 72 °C; samples were kept for 1 min at
60 °C for annealing and then heated from 55 to 99 °C with a ramp
of 0.3 °C/s to acquire data to produce the denaturing curve of the am-
pliﬁed products. Quantitative PCRs were made in a 20 μl ﬁnal volume
composed of 10 μl of each reverse transcription sample diluted
50–100 times, 2 μl of 10 times PCR buffer, 1.2 μl of 50 mM MgCl2,
0.4 μl of 5 mM dNTPs, 0.8 μl of 5 μM primer pairs, 3.55 μl of water,
2.0 μl of SYBRgreen (1:10,000 Molecular Probe), and 0.05 μl of Plati-
num Taq DNA polymerase (5 U/μl). All results were analyzed by the
2 −DDCT method (Livak and Schmittgen, 2001). TBP (TATA box
binding protein) was used as the internal control gene for all relative
expression calculations.
Immunoﬂuorescence
Twelve pups (six per group) were anesthetized using ketamine/
xylazine (75 and 10 mg/kg, respectively, i.p.) and were perfused
through the left cardiac ventricle with 40 ml of 0,9% saline solution,
followed by 40 ml of 4% paraformaldehyde in 0.1 M phosphate buff-
ered saline (PBS), pH 7.4, and the descendent aorta was clamped.
After the perfusion the brains were removed, post-ﬁxed in the same
ﬁxative solution for 4 h at room temperature and cryoprotected by
immersing in 15% and after in 30% sucrose solution in PBS at 4 °C.
The brains were then frozen by immersion in isopentane cooled
with CO2 and stored in a freezer (−80 °C) for later analyses. Serial
coronal sections (40 μm) of striatum were obtained using a cryostat
at−20 °C (Leica). Some sections were processed for double immuno-
ﬂuorescence for GFAP and NF-L and other sections for immunoﬂuo-
rescence for Neu-N (clone A60). The free-ﬂoating sections were
preincubated in 2% bovine serum albumin (BSA) diluted in PBS
containing 0.3% Triton X-100 (PBS-Triton X-100 0.3%) for 30 min.
Double immunoﬂuorescence of GFAP and NF-L, was carried out after
a two day incubation at 4 °C with rabbit polyclonal anti-GFAP and
mouse monoclonal anti-NF-L (clone NR-4), diluted 1:3000 and
1:2000, respectively, in PBS- Triton X-100 0.3%. For Neu-N immuno-
ﬂuorescence, the sections were incubated two overnights at 4 °C
with mouse polyclonal anti-NeuN diluted 1:1000 in PBS-Triton
X-100 0.3%. The negative controls were performed omitting the pri-
mary antibodies. After washing several times in PBS, tissue sections
were incubated with anti-rabbit Alexa 488 and anti-mouse Alexa
568, both diluted 1:500 in PBS-Triton X-100 0.3% for 1 h at room tem-
perature (for GFAP and NF-L immunoﬂuorescence). Other tissue sec-
tions were incubated with anti-mouse Alexa 488, diluted 1:500 in
Fig. 1. Effect of (PhTe)2 on the in vitro phosphorylation of IF proteins (A). Slices of stri-
atum were incubated in the presence of 32P orthophosphate, the cytoskeletal fraction
was extracted and the radioactivity incorporated into IF subunits was measured.
NF-H, high molecular weight NF subunit; NF-M, middle molecular weight NF subunit;
NF-L, low molecular weight NF subunit; Vim, vimentin and GFAP, glial ﬁbrillary acidic
protein. Representative stained gel and autoradiograph of the proteins studied are
shown (B). Data are reported as mean±S.E.M. of 8–10 animals and expressed as per-
cent of control. Statistically signiﬁcant differences from canola oil-treated rats, as de-
termined by one-way ANOVA followed by Tukey-Kramer test are indicated: *Pb0.05.
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noﬂuorescence). Afterwards, the sections were washed several times
in PBS, transferred to gelatinized slides, mounted with Fluor Save™
(Merck Rio de Janeiro, RJ), covered with coverslips and sealed with
nail polish. The images were obtained with an Olympus IX-81 confo-
cal FV-1000 microscope and analyzed with an Olympus Fluoview
software.
Flow cytometry analysis
Tissues were dissociated with PBS/Collagenase/DNase, washed once
with PBS then suspended in PBS/collagenase containing 10 μg/ml
propidium iodide (PI). The integrity of plasmamembrane was assessed
by determining the ability of cells to exclude PI. The cells were incubat-
ed at room temperature in the dark for 30 min, washed with PBS and
centrifuged at 3000 rpm for 5 min at 4 °C to remove the free PI. After-
wards, the cell was permeabilized with 0.2% PBS Triton X-100 in for
10 min at room temperature and blocked for 15 min with BSA 5%.
After blocking, cells were incubated in blocking solution containing
the monoclonal antibodies anti-NeuN (clone A60) diluted 1:100 or
anti-GFAP diluted 1:100, for 2 h. The cells were washed twice with
PBS and incubated for 1 h in blocking solution containing ﬂuorescein
isothiocyanate (FITC)-anti-rabbit IgG diluted 1:200 or Alexa 488-anti-
mouse IgG diluted 1:200. The levels of PI incorporation, levels of posi-
tive NeuN cells and positive GFAP cellswere determined byﬂow cytom-
etry (FACSCalibur, Becton Dickinson, Franklin Lakes, NJ, USA). FITC or
Alexa Fluor 488 and PI dyes were excited at 488 nm using an
air-cooled argon laser. Negative controls (samples with the secondary
antibody) were included for setting up the machine voltages. Controls
stainedwith a single dye (Alexaﬂuor 488 or FITC andpropidium iodide)
were used to set compensation. The emission of ﬂuorochromes was
recorded through speciﬁc band-pass ﬂuorescence ﬁlters: green (FL-1;
530 nm/30) and red (FL-3; 670 nm long pass). Fluorescence emissions
were collected using logarithmic ampliﬁcation. In brief, data from
10,000 events (intact cells) were acquired and the mean relative ﬂuo-
rescence intensity was determined after exclusion of debris events
from the data set. All ﬂow cytometric acquisitions and analyses were
performed using Flow Jo software 7.6.3 (Treestar, Ashland, OR). Flow
cytometry data were analyzed and plotted by density as a dot plot
which shows the relative FL1 ﬂuorescence on the x-axis and the relative
FL3 ﬂuorescence on the y-axis. The quadrants to determinate the nega-
tive and positive areawere placed on unstained samples. The number of
cells in each quadrantwas computed and the proportion of cells stained
with PI, GFAP and NeuN were expressed as percentage of PI uptake.
Protein determination
The protein concentration was determined by the method of
Lowry et al. (1951) using serum bovine albumin as the standard.
Statistical analysis
Data were analyzed statistically by one-way analysis of variance
(ANOVA) followed by the Tukey–Kramer multiple comparison test
when the F-test was signiﬁcant. All analyses were performed using
the SPSS software program on an IBM-PC compatible computer.
Results
We have previously described that a single administration of (PhTe)2
(0.3 μmol/kg body weight) caused hyperphosphorylation of IF proteins
from cortical slices of rats six days after injection (Heimfarth et al.,
2008). On the basis on these results, in the present report we attempted
to analyze the in vivo effects of (PhTe)2 on other cerebral structure.
Therefore, slices from striatum of rats injected with 0.3 μmol (PhTe)2/
kg body weight were incubated with 32P-orthophosphate and thephosphorylation pattern of astrocyte (GFAP and vimentin) as well as
neuron IF proteins (NF-L, NF-M and NF-H) were evaluated 6 days
post-exposure. As depicted in Fig. 1A, we found hyperphosphorylation
of all the striatal IF proteins studied. Fig. 1B shows a representative
experiment.
To examinewhether the in vivo treatmentwith (PhTe)2 affected sec-
ond messenger-independent and -dependent protein kinases we ana-
lyzed the involvement of MAPKs, PKA and PKCaMII respectively in the
actions of the neurotoxicant. Results showed that the MAPK signaling
is activated in striatal slices, as demonstrated by increased immunoreac-
tivity observed for phosphoErk (Fig. 2A), phosphop38MAPK (Fig. 2B)
and phosphoJNK (Fig. 2C), determined by Western blot analysis with
speciﬁc monoclonal antibodies. Fig. 2D shows representative blots of
total and phospho forms of the kinases studied. The effect (PhTe)2 on
PKA and PKCaMII activities are depicted in Fig. 3A. Results show an in-
creased striatal PKAcα immunoreactivity detected by Western blot
assay, while PKCaMII immunoreactivity was down-regulated in this
structure. Representative blot corroborate these ﬁndings.
In an attempt to identify the phosphorylating sites targeted by the
protein kinases PKCaMII, PKA and MAPK in the striatum, we assayed
NF-LSer57 and NF-LSer55 on NF-L head domain as well as KSP repeats
on NF-M/NF-H tail domain, respectively. As depicted in Fig. 3B, results
obtained with Western blot assay using anti-phosphoSer55 antibody
and anti-NFM/NFH KSP repeats showed that the phosphorylation
level at these sites, was increased following treatment with (PhTe)2.
These ﬁndings are consistent with a role for PKA and MAPKs in the
hyperphosphorylation of the neuronal IF proteins. On the other
Fig. 2. Effect of (PhTe)2 onMAPK pathways ERK1/2 (A), JNK (B) and p38MAPK (C) Representative Western blots of the proteins studied are shown (D). Data are reported as mean±
S.E.M. of 8–10 animals and expressed as percent of control. Statistically signiﬁcant differences from canola oil-treated rats, as determined by one-way ANOVA followed by Tukey–
Kramer test are indicated: *Pb0.05.
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roborating the evidence that PKCaMII is not involved in the action
of the neurotoxicant in this cerebral structure. Representative blots
are shown and corroborate these ﬁndings.
Next, we analyzed the effect of (PhTe)2 on the immunocontent of
the IF proteins from total striatal homogenate (Fig. 4A) or from protein
recovered into the high-salt Triton-insoluble cytoskeletal fraction of tis-
sue slices (Fig. 4C) at day 6 after the injection. We found that the
immunocontent of both GFAP and vimentin was signiﬁcantly increased
in the striatal homogenate and cytoskeletal fraction. However, the
immunocontent of the neuronal IFs (NF-L, NF-M and NF-H) was not al-
tered in response to (PhTe)2 injection. Figs. 4B and D are representative
immunoblot of the cytoskeletal proteins in total homogenate and in the
cytoskeletal fraction. Consistent with these results, RT-PCR analysis
showed over-expression of GFAP and vimentin mRNA, while expres-
sion of NF subunits was not altered (Fig. 5), supporting the hypothesis
of reactive astrogliosis in this cerebral structure.
For the purpose of assessing cell viability we proceeded with ﬂow
cytometry analysis using PI-exclusion assay to determine the percent-
age of viable cells. Results showed that (PhTe)2 signiﬁcantly increased
the number of Pi positive cells from 7.5% in controls to 11.5% at day 6
after exposure to the neurotoxicant (Fig. 6A). In addition, we used the
anti-NeuN antibody as a neuronal marker co-stained with PI to identify
neuronal damage. We found that Pi incorporation signiﬁcantly in-
creased from 30% in controls to 50% in neurons from injected animals
(Fig. 6B). Otherwise, PI incorporation into GFAP positive cells was not
altered in response to (PhTe)2 injection (Fig. 6C). Altogether, theseﬁnd-
ings indicate that in vivo exposure to (PhTe)2 provoked neuronal dam-
age, without inducing total neuronal loss, in striatum of rats at day 6after injection,. To further assess cell damage and cytoskeletal alter-
ations induced by the in vivo exposure to (PhTe)2, we proceeded with
immunoﬂuorescence analysis of striatal sections. Therefore, the sec-
tions were processed for double immunoﬂuorescence for GFAP and
NF-L and also for NeuN, and analyzed by confocal microscopy. As
depicted in Fig. 7A, the confocal analysis for GFAP showed a dramatic in-
crease of GFAP positive cells, and also reactive astrocytes were charac-
terized by increase in the size of the cell body and/or processes,
characteristic of reactive astrogliosis. Also, results from confocalmicros-
copy did not show decreased NF-L positive cells in (PhTe)2 treated
striatal slices (Fig. 7A), corroborating ourWestern blot analysis indicat-
ing that the neurotoxin failed to alter NF-L content. In addition, we did
not detect signiﬁcantly decreased immunoﬂuorescence for NeuN
(Fig. 7B).
Moreover, Western blot analysis with anti-caspase 3 antibody
showed that in (PhTe)2 treated striatal slices this key caspase is acti-
vated, indicating apoptotic cell death (Fig. 8A). In an attempt to deter-
mine signaling mechanisms involved in the neuronal damage we
evaluated the PI3K/Akt signaling pathway. Western blot analysis
using anti-Akt antibody showed decreased phosphoAkt immunoreac-
tivity (Fig. 8B) in (PhTe)2 treated slices, which is compatible with
down-regulated survival mechanisms in the striatum of treated ani-
mals (Zhao et al., 2006). Also, it was evaluated the GSK-3-β activity,
since it is described as a kinase that can be modulated by Akt activity
(Zhao et al., 2006). We found that phosphoGSK-3-β (Ser9) was not
altered in the striatum of (PhTe)2 injected rats, suggesting that this
kinase is not directly implicated in the neurotoxicity of this com-
pound (Fig. 8C). Fig. 8D depicts the representative immunological re-
action of active caspase 3, Akt and phosphoAkt.
Fig. 3. Effect of (PhTe)2 on total immunocontent of PKAcα and PKCaMII (A) and on the
immunocontent of phosphoNF-H KSP reapeats, phosphoNF-LSer55 and phosphoNF-
LSer57 (B). Representative Western blots of the proteins studied are shown. β-actin was
used as loading control. Data are reported as means±S.E.M. of 8–10 animals and
expressed as percent of control. Statistically signiﬁcant differences from canola
oil-treated rats, as determined by one-way ANOVA followed by Tukey–Kramer test are in-
dicated: *Pb0.05.
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We have previously demonstrated that young rats (15 day-old)
acutely injected with (PhTe)2 at 0.3 μmol/kg of body weight presented
weight loss from day 2 up to day 6 after drug exposure, indicating sys-
temic toxicity at this concentration (Heimfarth et al., 2008). In the pres-
ent study we attempted to further investigate the mechanisms
underlying neurotoxicity of (PhTe)2 in acutely injected 15 day-old
rats. We have chosen the striatum, since it is well known that, in ro-
dents, neurotoxins produce a number of neurochemical changes in
striatal glial and neuronal cells (Pierozan et al., 2012). Therefore, eluci-
dation of the biochemical steps leading to (PhTe)2-induced neurotoxic-
ity provide us new clues to the mechanisms underlying the actions of
this neurotoxin in brain.
Hyperphosphorylated IF proteins NF-L, NF-M and NF-H from neu-
rons as well as GFAP and vimentin from rat astrocytes reﬂect an altered
activity of the phosphorylating system associatedwith the IF proteins in
this cerebral structure. Despite the physiological role of NF phosphory-
lation is to date not completely clear, phosphorylation of amino-
terminal domain of NF-L and other IF subunits has been related to
their association into ﬁlamentous structures (for review see Sihag et
al., 2007), while in vitro phosphorylation of carboxyl-terminal domains
of NF-H and NF-M straightens individual NFs and promotes their align-
ment into bundles (Leterrier et al., 1996). Otherwise, the in vivophosphorylation of these proteins is associated with an increased
interNF spacing (Hsieh et al., 1994). As a consequence, NF-H and
NF-M carboxyl-terminal side arms extend and form cross-bridges
among NF and other cytoskeletal elements (Gotow et al., 1994).
There is a great deal of evidence suggesting that hyperphosphory-
lation of NF subunits is considered a hallmark of neurodegeneration
(for review see Perrot and Eyer, 2009). The present results are consis-
tent with this, since we ﬁrst observed that the acute administration of
(PhTe)2 in rats elicited hyperphosphorylation of GFAP, vimentin and
NF subunits, evidencing a response of the cytoskeleton of astrocytes
and neurons, to the action of the neurotoxicant. Accordingly,
NFLSer55 appeared to be a speciﬁc amino-terminal phosphorylation
site targeted by (PhTe)2, PKA being the most prominent protein ki-
nase mediating this effect.
It is important to note that PKA (Ser-55), PKC (Ser-51) and PKCaMII
(Ser-57) phosphorylation sites are relevant for ﬁlament assembly. Fur-
thermore, the phosphate present in Ser55 of NF-L is turned over rapidly
following NF-L synthesis in neurons (Sihag and Nixon, 1991),
suggesting a possible role in the blockade of NF assembly before their
transport into neurites. Like NF-L, PKA-mediated phosphorylation of
the head domain of GFAP inhibits ﬁlament assembly or induces disas-
sembly (Hisanaga et al., 1994). Therefore, our results showing NF-
LSer55 hyperphosphorylation suggest a key role of (PhTe)2 on IF dy-
namics preventing ﬁlament assembly and disassembling preexisting
ﬁlaments.
It is known that carboxyl-terminal phosphorylation of NF-H pro-
gressively restricts the association of NFs with kinesin, the axonal an-
terograde motor protein, and stimulates its interaction with dynein,
the axonal retrograde motor protein (Motil et al., 2006). This event
could represent one of the mechanisms by which carboxyl-terminal
phosphorylation would slow NF axonal transport. Consistent with
this, MAPK phosphorylates NF-M and NF-H tail domains at speciﬁc
carboxyl-terminal located KSP repeats (Veeranna et al., 1998) and al-
ters the association of NF with motor proteins (Yabe et al., 2000). It is
feasible that extensively phosphorylated KSP repeats on NF-M and
NF-H as well as MAPK (Erk, JNK and phospho38MAPK) activation
we found in the striatum of (PhTe)2-treated rats could interfere
with NF axonal transport and contribute, at least in part, to the neuro-
nal damage provoked by the neurotoxin. Taking into account the
present ﬁndings, we are tempted to speculate that disruption of cyto-
skeletal homeostasis in the striatum of injected rats, could be related
with the neurodegeneration provoked by the (PhTe)2. This hypothe-
sis is supported by the evidence that p38MAPK and JNK signaling
pathways are supposed to act synergistically upstream of mecha-
nisms leading to apoptotic neuronal death in different models of
neurodegeneration (Muscella et al., 2011).
To better understand the molecular mechanisms underlying neu-
ronal loss in acutely (PhTe)2 injected rats, we assayed the caspase 3
activity and we found that this caspase is activated 6 days after expo-
sure. Because activation of caspases, and caspase-3 in particular, ap-
pears to be a major factor for neuronal apoptosis execution in brain
(Yakovlev and Faden, 2001), the evaluation of upstream modulatory
mechanisms is important for understanding the regulation of the ap-
optotic process elicited by (PhTe)2. In this context, it is important to
note that release of cytochrome c from mitochondria plays critical
roles in the apoptotic cascade, activating caspase-9 which, in turn, ac-
tivates executioner caspase-3 and ‐7 (Slee et al., 1999). However,
more experiments will be needed to clarify the pathways involved
in the activation of caspase 3 in the striatum of (PhTe)2-treated rats.
Additional evidence of the pro-apoptotic mechanism of ac-
tion of (PhTe)2 comes from our results showing decreased Akt
phosphorylation/activity in striatal slices from injected animals. The
PI3K-Akt signaling pathway plays a critical role in mediating survival
signals in a wide range of neuronal cell types (Cardone et al., 1998).
The identiﬁcation of a number of substrates for the serine/threonine ki-
nase Akt suggests that it blocks cell death by both impinging on the
Fig. 4. Effect of (PhTe)2 on IF protein immunoreactivity in the tissue homogenate and in the cytoskeletal fraction. Immunocontent of IF proteins in the homogenate (A); in the cy-
toskeletal fraction (C). Representative Western blots of the proteins studied are shown (B,D). β-actin was used as loading control . Data are reported as means±S.E.M. of 8–10 an-
imals and expressed as percent of control. Statistically signiﬁcant differences from canola oil-treated rats, as determined by one-way ANOVA followed by Tukey–Kramer test are
indicated: *Pb0.05. NF-H, high molecular weight NF subunit; NF-M, middle molecular weight NF subunit; NF-L, low molecular weight NF subunit; Vim, vimentin and GFAP, glial
ﬁbrillary acidic protein.
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genes involved in cell death and survival (Koh et al., 2004). This is in
line with Zhou et al. (2000) who described that activated Akt may in-
hibit activation of caspase-9 and−3 by posttranslational modiﬁcation
of a cytosolic factor downstream of cytochrome c and before activation
of caspase-9 (Cardone et al., 1998). Therefore, inhibited PI3K-Akt
pathway, that was found in (PhTe)2, could be consistent with the apo-
ptotic insult observed in the striatum. Otherwise, GSK3β is a criticalFig. 5. Quantitative real-time PCR analysis in striatum of animals treated with (PhTe)2.
The expression of IF subunits was analyzed by real-time PCR six days after treatment.
Data represent mean±S.E.M. of 8–10 animals in each group. Statistically signiﬁcant
differences from controls determined by one-way ANOVA followed by Tukey–Kramer
test are indicated: *Pb0.05. NF-H, high molecular weight neuroﬁlament NF subunit;
NF-M, middle molecular weight NF subunit; NF-L, low molecular weight NF subunit,
Vim, vimentin and GFAP, glial ﬁbrillary acidic protein.downstream element of the PÌ3K/Akt pathway and its activity can be
inhibited by Akt-mediated phosphorylation at Ser9 (Srivastava and
Pandey, 1998). GSK3β has been implicated in multiple cellular process-
es and linkedwith the pathogenesis and neuronal loss in several neuro-
degenerative diseases (Petit-Paitel, 2010). In his context, Takashima
(2006) described that GSK-3β activation through impairment of PI3K/
Akt signaling was involved in amyloid-beta (Abeta)-induced neuronal
death in rat hippocampal cultures. However, in our experimental
model of (PhTe)2-induced neurodegeneration, Akt inhibition is ap-
parently not implicated in GSK3β (Ser9) hyperphosphorylation,
supporting different signaling pathways downstream of different
stressor events.
In the CNS, following injury, astrocytes become reactive, a promi-
nent process leading to the formation of the glial scar that inhibits
axon regeneration after CNS injury. Upon becoming reactive, astrocytes
undergo various molecular and morphological changes including
upregulation of their expression of GFAP, vimentin and chondroitin sul-
fate proteoglycans aswell as othermolecules that are inhibitory to axon
growth (Yu et al., 2012). However, upregulation of IFs is a hallmark of
astrogliosis and a well-accepted indicator of structural damage in the
CNS (Sofroniew and Vinters, 2010).
On the other hand, we detected an increased number of PI positive
neurons, however the total number of neurons was not decreased.
We can propose that neurons are damaged and probably they are in
death process. Thus, astrocytes could have become activated in re-
sponse to neuronal damage early after (PhTe)2 injection. In this con-
text, the neuronal damage showed by immunocytochemistry and
Fig. 6. Quantitative propidium iodide (PI) positive cells (A), neurons (B) and astrocytes (C) in (PhTe)2 injected rats. Total PI positive cells (A), NeuN-PI positive cells (B) and GFAP-PI
positive cells (C) were measured by ﬂow cytometry analysis. (D,E) representative ﬂow cytometry data. Data are reported as means±S.E.M. of 8–10 animals and expressed as per-
cent of control. Statistically signiﬁcant differences from canola oil-treated rats, as determined by one-way ANOVA followed by Tukey–Kramer test are indicated: *Pb0.05.
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vacuolization of cellular bodies of rat brain after in vivo exposure to
(PhTe)2, reported by Maciel et al. (2000).
Consistent with the pro-apoptotic effect of (PhTe)2 on striatal
neurons, we found a prominent increase of GFAP and vimentin ex-
pression apparent at 6 days post injection, which suggest that, at
least at this time, cells were reactive astrocytes. Astrogliosis is the
normal physiological response essential for damage containment.
However, it can also have detrimental effects on neuronal survival
and axon regeneration, particularly in neurodegenerative insults. It
is believed that progressive changes in astrocytes as they become re-
active are ﬁnely regulated by complex intercellular and intracellular
signaling mechanisms. Reports describing whether the MAPK path-
ways are upregulated in astrocytes in vivo are mixed. Nonetheless,Fig. 7. Immunohistochemistry for GFAP, NF-L, NeuN and merged. The panels obtained by co
meaning astrogliosis and decreased neuronal integrity in the striatum of (PhTe)2 injected rat
of 6 animals. Bar scale=30 μm (magniﬁcation: 40×); 50 μm (magniﬁcation: 20×).increased phosphorylation level of Erk and/or p38MAPK takes part
in the response of astrocytes to insults (Ito et al., 2009). Although
the evident complexity involving the participation of these signaling
mechanisms in reactive astrogliosis, different components of MAPK
signaling are activated under distinct pathological conditions and in
different cell types, which may indicate a common mechanism.
Thus, the activation of MAPKs detected in the striatum of acutely
treated rats could be associated with the program of astrogliosis
detected in our experimental condition.
Conclusion
In the present study we demonstrate that the neurotoxicant
(PhTe)2 administered s.c. is able to elicit a cell response throughnfocal microscopy show increased GFAP, unaltered NF-L and decreased NeuN staining,
s. Merged panels show colocalization of astrocytes and neurons. Representative images
Fig. 8. Effect of (PhTe)2 on caspase (A), AKT/PKB (B) and GSK3β (C) pathways in the striatum of rats. Total immunocontent of active caspase 3 (A); total and phosphoAKT (B); and
total and phosphoGSK3β (C). Representative Western blots of the proteins studied are shown (D). β-actin was used as loading control. Data are reported as means±S.E.M. of 8–10
animals and expressed as percent of control. Statistically signiﬁcant differences from canola oil-treated rats, as determined by one-way ANOVA followed by Tukey-Kramer test are
indicated: *Pb0.05.
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striatum of young rats. At present we do not know if the effect of
the neurotoxicant is directly on the neural cell or if it is a consequence
of the activation of other stress responses, like neuroinﬂammation.
Further studies will be necessary to clarify this point.
Taking into account the present results, the proposed mechanism
for the action of (PhTe)2 in the striatum of young rats is summarized
in Fig. 9. We think these results shed light into the mechanisms of
(PhTe)2-induced neurodegeneration in rat striatum, evidencing a
critical role for the PKA, MAPK and Akt signaling pathways causing
disruption of cytoskeletal homeostasis, which could be related with
apoptotic neuronal death and astrogliosis.Fig. 9. Schematic representation of themechanismsof (PhTe)2-inducedneurodegeneration
in rat striatum. The neurotoxicant injected in 15 day-old rats activated signaling pathways
6 days after injection. The molecular mechanisms involved PKA, MAPK and caspase 3 acti-
vation and Akt inhibition, causing disruption of cytoskeletal homeostasis, which in turn,
could be related with the apoptotic process of neuronal cells and astrogliosis.Conﬂict of interest statement
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